OverviewSuggest Edit

NeuroMetrix is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company currently markets products for the detection, diagnosis, and monitoring of diabetic neuropathies such as diabetic peripheral neuropathy and median neuropathy (carpal tunnel syndrome).
TypePublic
Founded1996
HQWoburn, MA, US
Websiteneurometrix.com
Employee Ratings3.3
Overall CultureA+

Latest Updates

Employees (est.) (Dec 2019)23(-45%)
Revenue (FY, 2019)$9.3 M(-42%)
Share Price (Jan 2021)$3.9 (+6%)
Cybersecurity ratingBMore

Key People/Management at Neurometrix

David E. Goodman

David E. Goodman

Director
Shai N. Gozani

Shai N. Gozani

Chairman of the Board, President, and Chief Executive Officer
Thomas T. Higgins

Thomas T. Higgins

Senior Vice President and Chief Financial Officer
Nancy E. Katz

Nancy E. Katz

Director
Michael J. MacDonald

Michael J. MacDonald

Senior Vice President and General Manager, Diagnostics
Xuan Kong

Xuan Kong

Chief Data Scientist
Show more

Neurometrix Office Locations

Neurometrix has an office in Woburn
Woburn, MA, US (HQ)
4 Gill St
Show all (1)

Neurometrix Financials and Metrics

Neurometrix Revenue

Embed Graph
View revenue for all periods
Neurometrix's revenue was reported to be $9.27 m in FY, 2019
USD

Revenue (Q3, 2020)

2.0m

Gross profit (Q3, 2020)

1.5m

Gross profit margin (Q3, 2020), %

73.6%

Net income (Q3, 2020)

(257.1k)

EBIT (Q3, 2020)

(257.9k)

Market capitalization (20-Jan-2021)

14.8m

Closing stock price (20-Jan-2021)

3.9

Cash (30-Sept-2020)

4.9m

EV

11.1m
Neurometrix's current market capitalization is $14.8 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

10.4m7.6m5.3m5.5m7.3m12.0m17.1m16.1m9.3m

Cost of goods sold

4.7m3.6m2.2m2.6m4.0m7.1m10.2m8.7m7.0m

Gross profit

5.7m4.0m3.1m2.9m3.3m4.9m6.9m7.4m2.2m

Gross profit Margin, %

55%53%58%53%46%41%40%46%24%
USDQ2, 2011

Financial Leverage

1.2 x
Show all financial metrics

Neurometrix Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

Neurometrix Online and Social Media Presence

Embed Graph

Neurometrix Company Culture

  • Overall Culture

    A+

    96/100

  • CEO Rating

    A+

    100/100

  • Compensation

    A+

    100/100

Learn more on Comparably

Neurometrix News and Updates

NeuroMetrix, Inc. Announces Date for Third Quarter 2020 Financial Results Conference Call

WOBURN, Mass., Oct. 15, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 third quarter financial results before the opening of the market on October 22, 2020. The Company will host a conference call at 8:00 a.m., Eastern Time on October 22, 2…

NeuroMetrix Announces Issuance of New U.S. Patent for Quell® Wearable Technology

WOBURN, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office will issue on September 22, 2020 U.S. Patent No. 10,780,269 titled “Apparatus and Method for Relieving Pain Using Transcutaneous Electrical Nerve Stimulation…

NeuroMetrix Reports Q2 2020 Financial Results

WOBURN, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2020. The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic health co…

NeuroMetrix Reports Q4 and Full Year 2019 Financial Results

WOBURN, Mass., Jan. 27, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and year ended December 31, 2019.

NeuroMetrix Reports Q3 2019 Financial Results

WOBURN, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2019.

NeuroMetrix, Inc. Announces Date for Second Quarter 2019 Financial Results Conference Call

WALTHAM, Mass., July 11, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 second quarter financial results before the opening of the market on Thursday, July 18, 2019. The Company will host a conference call at 8:00 a.m., Eastern Time on July…
Show more

Neurometrix Frequently Asked Questions

  • When was Neurometrix founded?

    Neurometrix was founded in 1996.

  • Who are Neurometrix key executives?

    Neurometrix's key executives are David E. Goodman, Shai N. Gozani and Thomas T. Higgins.

  • How many employees does Neurometrix have?

    Neurometrix has 23 employees.

  • What is Neurometrix revenue?

    Latest Neurometrix annual revenue is $9.3 m.

  • What is Neurometrix revenue per employee?

    Latest Neurometrix revenue per employee is $403.2 k.

  • Who are Neurometrix competitors?

    Competitors of Neurometrix include Yes Health, Biop Medical and Intuity Medical.

  • Where is Neurometrix headquarters?

    Neurometrix headquarters is located at 4 Gill St, Woburn.

  • Where are Neurometrix offices?

    Neurometrix has an office in Woburn.

  • How many offices does Neurometrix have?

    Neurometrix has 1 office.